Peptide Therapeutics Market Landscape, Application, Development, Analysis And Forecasts To 2025

Nevertheless, the large scale production of peptide with increasing complexities of peptides is a major challenge
for peptide therapeutics market. The development of multifunctional peptides and rise in number of
collaboration for the progress of peptide conjugates are currently ruling the market.
Latest advances in peptide synthesis technology is projected to be the key driver for the growth of peptide
therapeutics industry. From among the different methods of peptide synthesis, enzymatic and chemical
synthesis are important. This technology has integrated structure-activity relationships (SARs) and analog
generation to increase bioavailability, increase safety & efficacy of drugs, impart protease resistance, reduce
adverse effects, and develop formulations.
The other driving factor of the market is the shift towards unexploited market. The market is witnessing several
vendors focusing on developing economies due to presence of large population groups and clinical trial subjects.
Factors like presence of lenient regulatory guidelines, skilled labor, limited market competition, and low
manufacturing costs will encourage vendors to shift their manufacturing processes to the developing
economies.
Peptide therapeutics market is categorized on the basis of application, technology, route of administration,
molecule type, API peptide type, and geography. On the basis of application, the market is divided into Cancer,
Metabolic, CVD, Respiratory, GIT, Anti-infective, Dermatology, CNS, Renal, etc. In terms of route of
administration, the market is segmented as Parenteral, Oral, etc.
Browse Full Research Report @
https://www.millioninsights.com/industry-reports/peptide-therapeutics-market
On the basis of type, peptide therapeutics industry is divided into Innovative and Generic. On the basis of
technology, the market is classified into Liquid Phase, Solid Phase, and Hybrid Phase. Type of Molecule is
classified into Vasopressin, Somatostatin, Calcitonin, Immunopeptide, Natriuretic, and others. On the basis of
API Peptide Type, the market is divided into In-house, and CMO (contract manufacturing organization).
Geographically, peptide therapeutics market is segmented as North America, Latin America, Europe, Asia Pacific,
and Middle East & Africa. North America and Latin America are predicted to hold larger share of the market
owing to the rising incidences of cancer and other life-style related disorders.
The key peptide therapeutics industry players comprise AstraZeneca plc, Amgen Inc., Eli Lilly and Company,
Sanofi, CordenPharma International GmbH, Teva Pharmaceutical Industries Ltd., Novartis AG, Ipsen S.A., Lonza
Group Ltd., Merck & Co. Inc., F. Hoffmann-La Roche AG, Bachem Holding AG, PolyPeptide Group and Novo
Nordisk A/S.
Market Segment:
Peptide Therapeutics, Application Outlook (Revenue, USD Million; 2014 - 2025)
• Cancers